Next-Generation Minimally Invasive Anti-Aging Therapy: Incorporation of Resveratrol-Nicotinamide Cerosomes into PLGA Microneedles for Enhanced Skin Permeation
<b>Background/Objectives</b>: Skin aging and wrinkle formation are primarily driven by ultraviolet (UV)-induced oxidative stress and inflammation. Resveratrol (RSV) and nicotinamide (NCT) possess potent anti-aging properties but suffer from poor skin penetration. This study aimed to develop an advanced transdermal delivery system incorporating RSV/NCT-loaded cerosomes within poly(lactic-co-glycolic acid) (PLGA) microneedles to enhance skin permeation and anti-aging performance. <b>Methods</b>: RSV/NCT-loaded cerosomes were formulated using thin-film hydration of phosphatidylcholine, ceramides (III, IIIB, and VI), and poloxamer surfactants, subsequently optimized via a D-optimal mixture design. PLGA microneedles with optimized cerosomes were tested for their mechanical strength, penetration, drug loading, and release. Ex vivo permeation and in vivo evaluations were performed using a UVA-induced skin wrinkling model. <b>Results</b>: Optimized cerosomes exhibited high entrapment efficiency for RSV and NCT (91 ± 0.56% and 85 ± 0.56%, respectively), nanoscale size (195 ± 0.78 nm), low polydispersity (0.23 ± 0.01), and a negative zeta potential (-22 ± 0.45 mV). PLGA microneedles exhibited sufficient mechanical integrity and effective penetrability through Parafilm<sup>®</sup> layers. Microneedle-loaded cerosomes enabled sustained drug release (approximately 65-70% over 48 h) and enhanced ex vivo permeation, approximately for NCT and RSV (1450 μg/cm<sup>2</sup> and 1000 μg/cm<sup>2</sup>, respectively). In vivo investigations revealed improved skin appearance, restoration of epidermal thickness and collagen architecture, reduced levels of inflammatory cytokines (TNF-α, IL-1β, IL-6, NLRP3), reduced oxidative stress biomarkers (GSH, GPx, MDA, SOD), and genetic upregulation of VEGF, TGF-β1, and β-Catenin. <b>Conclusions</b>: The RSV/NCT cerosome-encapsulated PLGA microneedle system offers a promising, minimally invasive approach with superior transdermal delivery, sustained efficacy, and significant anti-aging benefits.
Authors
- Ahmed Mohsen Faheem
- Amal Anwar Taha (ORCID: https://orcid.org/0000-0001-8477-4027)
- Sammar Fathy Elhabal (ORCID: https://orcid.org/0000-0002-7970-2288)
- Shady Allam (ORCID: https://orcid.org/0000-0002-5633-4128)
- Mai S. Shoela (ORCID: https://orcid.org/0000-0001-7404-3191)
- AMANY ALI KHALIL NAWAR (ORCID: https://orcid.org/0009-0004-8098-9687)
- Marwa A. Fouad
- Amal M. Elsharkawy
- Mona Mohamed Ahmed
- Suzan Awad AbdelGhany Morsy
- Fatma E. Hassan
- Hanan Mohamed Abd Elmoneim
- Ahmed Mohsen Elsaid Hamdan
Institutions
- Cairo University (EG)
- Misr University for Science and Technology (EG)
- Mansoura University (EG)
- Umm al-Qura University (SA)
- Ibn Sina National College for Medical Studies (SA)
- Fahd bin Sultan University (SA)
- Modern University for Information and Technology (EG)
- University of Jeddah (SA)
- Soliman Fakeeh Hospital (SA)
- Batterjee Medical College
- Deraya University
- Menoufia University (EG)
- University of Tabuk (SA)
- Alexandria University (EG)
- Minia University (EG)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3390/pharmaceutics18030326
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00